[1] |
Casanova, J.L., Blanche, S., Emile, J.F., Jouanguy, E., Lamhamedi, S., Altare, F., Stephan, J.L., Bernaudin, F., Bordigoni, P., Turck, D., Lachaux, A., Albertini, M., Bourrillon, A., Dommergues, J.P., Pocidalo, M.A., Le-Deist, F., Gaillard, J.L., Griscelli, C., Fischer, A., 1996. Idiopathic disseminated bacillus Calmette- Guerin infection: a French national retrospective study. Pediatrics. 98, 774-778.
|
[2] |
Casanova, J.L., Jouanguy, E., Lamhamedi, S., Blanche, S., Fischer, A., 1995. Immunological conditions of children with BCG disseminated infection. Lancet. 346, 581.
|
[3] |
Hagiya, H., Koyama, T., Zamami, Y., Minato, Y., Tatebe, Y., Mikami, N., Teratani, Y., Ohshima, A., Shinomiya, K., Kitamura, Y., Sendo, T., Hinotsu, S., Tomono, K., Kano, M.R., 2018. Trends in incidence and mortality of tuberculosis in Japan: a population-based study, 1997-2016. Epidemiol. Infect. 1-10.
|
[4] |
Lotte, A., Wasz-Hockert, O., Poisson, N., Dumitrescu, N., Verron, M., Couvet, E., 1984. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 21, 107-193.
|
[5] |
Lotte, A., Wasz-Hockert, O., Poisson, N., Engbaek, H., Landmann, H., Quast, U., Andrasofszky, B., Lugosi, L., Vadasz, I., Mihailescu, P., 1988. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull. Int. Union. Tuberc. Lung. Dis. 63, 47-59.
|
[6] |
Norouzi, S., Aghamohammadi, A., Mamishi, S., Rosenzweig, S.D., Rezaei, N., 2012. Bacillus Calmette-Guerin (BCG) complications associated with primary immunodeficiency diseases. J. Infect. 64, 543-554.
|
[7] |
Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., Cunningham-Rundles, C., Etzioni, A., Holland, S.M., Klein, C., Nonoyama, S., Ochs, H.D., Oksenhendler, E., Puck, J.M., Sullivan, K.E., Tang, M.L., Franco, J.L., Gaspar, H.B. 2015. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J. Clin. Immunol. 35, 696-726.
|
[8] |
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H.L., Committee, A.L.Q.A., 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405-424.
|
[9] |
Talbot, E.A., Perkins, M.D., Silva, S.F., Frothingham, R., 1997. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin. Infect. Dis. 24, 1139-1146.
|
[10] |
World Health Organisation (WHO), 2004. BCG vaccine. WHO position paper. Wkly. Epidemiol. Rec. 79: 27-38.
|
[11] |
World Health Organization (WHO), 2018. Global tuberculosis report 2018. WHO: Geneva, Switzerland.
|
[12] |
Xu, H., Tian, W., Li, S.J., Zhang, L.Y., Liu, W., Zhao, Y., Zhang, Z.Y., Tang, X.M., Wang, M., Wu, D.Q., Shi, J.S., Ding, Y., Zhao, X.D., Yang X.Q., Jiang, L.P., 2014. Clinical and Molecular Features of 38 Children with Chronic Granulomatous Disease in Mainland China. J. Clin. Immunol. 34, 633-641.
|
[13] |
Yang, Y.H., 2013. Pediatric Vaccinology. Beijing: Beijing Science and Technology Press. 150-203.
|